Drug Development Groups Life Science Survey 
Henry Kotula
MARCH 10, 2021
The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. As the U.S. As the U.S. Healthcare and pharma companies seem to be more bullish on AI than other industries are.
Digital Health Global
NOVEMBER 30, 2023
Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development.
Healthcare IT Today
JANUARY 17, 2024
We asked the Healthcare IT Today community to submit their predictions and we received a wide ranging set of responses that we grouped into a number of themes. As we kick off 2024, we wanted to start the new year with a series of 2024 Health IT predictions.
Expert insights. Personalized for you.
41 
Let's personalize your content